GoldenGolden
Advanced Search
BioAdvance

BioAdvance

BioAdvance invests in companies developing technologies in sectors of therapeutics, research tools, medical devices, diagnostics, and health information technology.

Founded in 2002, BioAdvance is a venture capital firm based in Radnor, Pennsylvania. The firm seeks to invest in health-tech firms including therapeutics, medical devices, diagnostics, research tools and healthcare IT sectors located in the mid-Atlantic region.

BioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its new $50 million Greenhouse Fund.

Since its first investments, BioAdvance has committed more than $40 million to more than 50 seed-stage companies and 17 pre-seed companies. Their portfolio companies are working to develop products to treat health problems including Alzheimer's disease, cancer, obesity, GI disorders, neurological and respiratory illnesses. BioAdvance was established with $33 million from the Commonwealth of Pennsylvania's share of tobacco settlement.

Investment

BioAdvance's investments include Novira Therapeutics, Immunome, Halo Labs, Leversense, Niiki Pharma, Solaris Therapeutics, Galleon Pharmaceuticals, Cool-Bio and CarePartners Plus.

Their exited investments include Advaxis, Relmada Therapeutics, Novira Therapeutics, NuPathe, HealthQx, Ceptaris Therapeutics, Avid Radiopharmaceuticals, Acuity Pharmaceuticals, Protez Pharmaceuticals and Immune Control.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.